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Abstract 
It is well established that in regions where malaria is endemic the sickle cell allele 
HBB*S is usually found at high frequency due to it being associated with resistance to 
the disease. When in homozygosity, it is responsible for the Sickle Cell Anemia (SCA), 
which in Portugal reaches the highest prevalence in south-central regions. This 
distribution seems to be explained by the pattern of population migrations that marked 
the past of these regions.   
In order to better understand the presence of Sickle Cell Diseases (SCD) in Portugal, 
this project aimed at screening the HBB gene in three population samples from Alentejo 
- Coruche, Serpa (Pias) and Alcácer do Sal, and further infer the origin of the most 
common variant, HBB*S, through the analysis of the haplotypic background 
encompassing the entire cluster of β-globin genes. 
In this sense, and as an alternative to the conventional haplotyping strategy based 
on the analysis of Restriction Fragment Length Polymorphism (RFLP), a SNaPshot® 
Multiplex system was implemented targeting the most informative positions defining 
HBB*S haplotypes, and then applied to examine HBB*S-bearing individuals previously 
identified by Sanger sequencing. 
In a total of 266 individuals analysed, 19 harboured the c.20A>T mutation that 
underlies HBB*S. The variant HBB*C was not detected in any sample.  
The frequencies of HBB*S were 2.2, 2.9 and 7.7% in Coruche, Alcácer do Sal and 
Serpa respectively, with the estimate for Serpa being the highest up to now reported for 
Portugal, where foci of high prevalence of HBB*S carries have been described in the 
South of country. 
Among the chromosomes of the 19 individuals bearing the HBB*S allele, 29% 
harboured the Benin haplotype, 13.1% the Senegal and 10.5% the Bantu. Remarkably, 
whereas in Alcáçer do Sal and Coruche only Senegal and Bantu haplotypes were found, 
in Serpa all haplotypes were Benin. 
Taking into account the global distribution of HBB*S haplotypes, the findings here 
obtained reinforce a scenario before proposed positing that the introduction of HBB*S in 
south Portugal was mediated by gene influx events with distinct sources: one from the 
region encompassing the Mediterranean basin (captured by the Benin haplotype), and 
other from sub-Saharan Africa, likely afforded by the transatlantic slave trade (captured 
by the Senegal and Bantu haplotypes). 
Besides HBB*S, two β-thalassemia variants, already reported as amongst the most 
common in Portugal, were also identified: HbVar.827 (two heterozygous from Coruche) 
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and HbVar.845 (one heterozygous from Alcácer do Sal, one from Serpa and three from 
Coruche). 
Globally, this study provides a refreshed perspective on the epidemiology of 
hemoglobinopathies in south Portugal. 
 
 
Keywords: Sickle Cell Disease (SCD); Portugal; Alentejo; Álcacer do Sal; Serpa; 
Coruche; HBB gene; Single Nucleotide Polymorphisms (SNPs); SNaPshot® Multiplex; 
Haplotypes. 
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Resumo 
Está bem estabelecido que em regiões onde a malária é endémica se regista 
elevada frequência da variante HBB*S, por ser um alelo que confere resistência à 
malária. Quando em homozigotia, é responsável pela Anemia Falciforme, que em 
Portugal atinge uma maior prevalência nas regiões centro-sul. Esta destribuição parece 
resultar dos padrões de migrações populacionais que marcaram o passado dessas 
regiões. 
Tendo em vista uma análise mais fina da distribuição da Anemia Falciforme no sul 
de Portugal, com este projeto pretendeu-se efetuar o despiste de mutações no gene 
HBB em amostras populacionais do Alentejo - Coruche, Serpa (Pias) e Alcácer do Sal, 
e inferir a origem das variantes mais comuns, nomeadamente HBB*S, através do 
respetivo estudo haplotípico envolvendo o cluster de genes da globina-β. 
Nesse sentido, e em alternativa à estratégia convencional de haplotipagem baseada 
no estudo de Restriction Fragment Length Polymorphism (RFLP), uma técnica baseada 
em SNaPshot® Multiplex foi desenvolvida para a análise dos polimorfismos mais 
informativos que definem os haplótipos HBB*S, e aplicada nas amostras em que esse 
alelo tinha sido previamente identificado por sequenciação de Sanger. 
Em 266 individuos analisados, 19 apresentaram a mutação c.20A>T que define o 
alelo HBB*S. A variante HBB*C não foi detetada em nenhuma amostra. 
As estimativas de frequência de HBB*S foram 2.2, 2.9 e 7.7% em Coruche, Alcácer 
do Sal e em Serpa respectivamnete, com a última sendo a mais alta alguma vez 
reportada em Portugal, onde foci de alta prevalência de portadores de HBB*S foram 
anteriormente descritos no sul do país. 
Entre os cromossomas dos 19 individuos portadores do alelo HBB*S, 29% 
apresentavam o haplótipo Benin, 13.1% o Senegal e 10.5% o Bantu. De notar, que 
enquanto em Alcácer do Sal e Coruche apenas os haplótipos Senegal e Bantu foram 
encontrados, em Serpa foram apenas detetados haplótipos Benin.  
Atendendo à destribuição global dos haplótipos associados ao alelo HBB*S, os 
dados agora obtidos reinforçam um cenário proposto anteriormente, segundo o qual a 
introdução HBB*S no sul de Portugal foi mediado por fluxos migratórios com origens 
distintas: um proveniente da região que engloba toda a bacia Mediterrânica (associado 
ao haplótipo Benin), e outro da África Subsaariana, muito provavelmente decorrente do 
tráfico de escravos (associado aos haplótipos Senegal e Bantu). 
Além do alelo HBB*S, duas variantes de β-talassemia, anteriormente descritas entre 
as mais comuns em Portugal, foram também identificadas: HbVar.827 (duas amostras 
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heterozigóticas de Coruche) e HbVar.845 (uma amostra heterozigótica de Alcácer do 
Sal, uma de Serpa e três de Coruche). 
Em suma, este estudo fornece uma perpectiva atualizada relativa à epidemiologia 
das hemoglobinopatias no sul de Portugal. 
 
 
Palavras-Chave: Anemia Falciforme; Portugal; Alentejo; Álcacer do Sal; Serpa; 
Coruche; gene HBB; Single Nucleotide Polymorphisms (SNPs); SNaPshot® Multiplex; 
Haplótipos. 
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1. State of Art 
1.1. Blood Components 
In an average adult, 4 to 5 litres is the amount of blood that courses through the body, 
allowing the distribution of elements necessary for the normal function of each organ. 
The blood is constituted mainly by four different components, each one with different 
particular functions: plasma, leukocytes and phagocytic cells (white blood cells), platelets 
and erythrocytes (red blood cells (RBC)) (Rogers, 2010). 
The plasma it’s what allows the transport of the mentioned cells, being constituted 
by about 7 percent of proteins (such as serum albumin, that represent 60 percent of 
plasma proteins, globulins and fibrinogen) and more than 90 percent water, which gives 
the fluidity consistent to the solution (Rogers, 2010; Sherwood, 2015). 
White blood cells are involved in the process of immunity, protecting the body against 
infections and diseases, where the exogenous microorganisms and particles can be 
ingested and destroyed, or by the production of antibodies.  
The platelets, that are small cells with 2 to 4 micrometres of diameter, have as main 
function the controlling of bleedings, by attaching to the injured endothelial surface of 
blood vessels, and also the blockage of the entering of exogenous microorganisms to 
the blood flow, avoiding the infection process (Rogers, 2010). 
Last but not least, erythrocytes, which account to about 45 percent of the blood 
volume, existing on average 5 billion RBC in each millilitre of blood. The cells lacks nuclei 
and mitochondria, and are disc-shaped with a flattened center that provides an increased 
surface area for its main function, the carrying of oxygen from the lung and its diffusion 
to all the body tissues. The process is mediated by hemoglobin (Hb), and each 
erythrocyte can contain approximately 280 million of these molecules (Fox, 2011; 
Rogers, 2010; Sherwood, 2015). This protein will be deeply dissected in the next section. 
 
1.2. Hemoglobin  
As a colored pigment overwhelmingly found in erythrocytes, hemoglobin is the 
protein that gives the recognised red shade to the blood (Honig and Adams, 1986; 
Sherwood, 2015). It is a tetrameric protein, having a quaternary structure of four 
polypeptide chains (also titled subunits). Adult hemoglobin, known as HbA, is composed 
by two alpha-globin (α) and two beta-globin (β), commonly represented as α2β2 (Baldwin 
and Chothia, 1979; Honig and Adams, 1986; Jensen et al., 1998). 
For an effective transport of oxygen through the body, oxygen needs to be able to 
interact with the transporter, but since the amino-acid chains of the globins are not able 
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to do the binding irreversible, that is assisted by a protein-bound prosthetic group, the 
heme (Nelson and Cox, 2012). 
Each subunit has a reversible oxygen-binding heme group that consists of an organic 
ring structure called protoporphyrin that has an iron atom linked in its ferrous (Fe2+) state. 
Is to the iron atom that the actual binding of the oxygen occurs (Figure 1) (Nelson and 
Cox, 2012). 
 
 
Although the function of the protein remains the same, there are actually different 
hemoglobin types, which switch since the time of conception until 48 weeks postnatal 
age, persisting thereafter through adulthood, probably because of the variation in oxygen 
requirements during those different times (Weatherall, 2013).  
The globins belong to a superfamily that contains two groups, the “α-like” and the “β-
like”, encompassing the two kinds of globin chains necessary for the arrangement of 
different haemoglobin forms. Within each globin group, there is more than one gene that 
can be translated, allowing the production of more than one α- and β-like globin. The set 
of genes that code for each globin type, are therefore designated as “α-cluster” and “β-
cluster” (Griffiths, 2008). 
 
1.2.1. Hemoglobin Genes 
Located in the short arm of chromosome 16 in band p13.3, the α-cluster spans a 
region of 30kb comprising three genes: HBZ (ζ), HBA2 (α2) and HBA1 (α1); and four 
pseudogenes (HBZP1 (ψζ), HBM (ψα2) HBAP1 (ψα1) and HBQ1 (θ1)). The cluster lies in 
a GC rich area associated with unmetylated CpG islands (Brittain, 2002; Grosveld et al., 
1993; Weatherall, 2013). 
Figure 1 - Hemoglobin molecule and representation of each subunit and heme groups (adapted from Sherwood (2015)). 
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On the other hand, the β-cluster is constituted by the genes HBE1 (ε), HBG2 (Gɣ), 
HBG1 (Aɣ), HBD (δ) and HBB (β) and the pseudogene HBBP1 (ψβ), being positioned in 
an AT rich region of the short arm of chromosome 11, band p15.5, covering 
approximately 70kb of DNA. The difference between genes Gɣ and Aɣ lies on a single 
substitution that results in products of expression with identical length, though differing 
at amino-acid residue 136, which in Gɣ is glycine and in Aɣ is alanine (Brittain, 2002; 
Grosveld et al., 1993; Weatherall, 2013). 
In spite of the different chromosomal location of the two clusters, they share many 
common characteristics. In addition of having pseudogenes – duplicate copies of genes 
that accumulated random mutations making them non-functional – the gene members in 
both cluster are organized in a sequence that recapitulates the temporal order of 
appearance of the polypeptides in the course of human development (Figure 2) (Brittain, 
2002; Griffiths, 2008; Grosveld et al., 1993; Weatherall, 2013). 
 
 
1.2.2. Normal Human Hemoglobins 
The association of the different globin types, results in the repertoire of hemoglobins 
that are produced to respond to the variation of oxygen requirements in particular times 
of human life. During the first two weeks, the embryo is small enough to get the oxygen 
by simple diffusion processes, however, as long as he growths this process is no longer 
sufficient to meet the metabolic demands, and therefore, not much before of the fourth 
week of gestation, three different forms of embryonic hemoglobins start to being 
produced: Portland (ζ2ɣ2), Gower 1 (ζ2ε2) and Gower 2 (α2ε2) (Brittain, 2002; Grosveld et 
al., 1993; Weatherall, 2013). 
At 10 weeks post-conception, the amount of embryonic hemoglobins drastically 
decreases, and the production of the fetal hemoglobin (HbF, α2ɣ2) sets on, remaining the 
predominant hemoglobin for the rest of gestation. Approaching the 38th week of 
postconceptional age, a second switch occurs leading to an almost silencing of fetal 
hemoglobin expression while adult hemoglobin began to be predominantly produced. 
Therefore, in adults there is the production of HbA (α2β2), HbA2 (α2δ2), the major and 
Figure 2 – Representation of α-cluster and β-cluster genes (adapted from Kaushansky et al. (2010)). 
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minor forms of hemoglobin that account to ~ 97% and ~2% of total hemoglobin, 
respectively, and a residual proportion of HbF (<1%) (Bard, 1973; Grosveld et al., 1993; 
Weatherall, 2013). 
 
1.3.  Hemoglobin Genetic Disorders 
Also designated as hemoglobinopathies, the genetic disorders of Hb are the most 
common world-wide among the inherited diseases typically associated with an 
autosomal recessive transmission pattern (Costa et al., 2016). Affecting approximately 
7% of the world’s population, the conditions are mainly diagnosed through blood tests 
that include analyses of the quantity and quality of hemoglobin (Hoffbrand et al., 2006). 
The two main groups of disorders are thalassemias and structural variants of 
hemoglobin; each one separately can result in diseases with a large range of severity, 
although carriers of some genetic mutations can be phenotypically normal. The 
combination of genetic alterations underlying the two groups of disorders is also possible 
resulting once again in diverse clinical and pathological manifestations. Together with 
the large variety of mutations that can affect the globin genes, many other factors can 
modulate the phenotypic manifestation of the diseases (Bridges and Pearson, 2008; 
Corrons, 2001) 
 
1.3.1. α and β-thalassemias  
Thalassemias, the commonest monogenic diseases in man, are caused by an 
imbalanced rate of production of normal globin chains of adult hemoglobin. They are 
divided into α0-/β0- and α+-/β+- depending on whether the mutation abolishes completely 
the production of the protein, or diminishes its production, respectively (Flint et al., 1998; 
Kaushansky et al., 2010). 
This abnormalities can be caused by gene deletion or by mutations that affect the 
transcription of mRNA (by the creation of new splice sites in introns or exons), its 
translation (by amino-acid substitution encoding a chain terminator codon) or the stability 
of the molecule (Clarke and Higgins, 2000; Kaushansky et al., 2010). In consequence, 
the excess of unpaired globin chains can precipitate and damage the membrane of 
erythrocytes, causing their premature destruction (Steinberg et al., 2009). 
Since α-globin is expressed on fetus and adults, α-thalassemia causes pre- and 
postnatal disease. The range of severity can go from mild anemia, also referred to as α-
thalassemia trait, to Hb Bart’s hydrops fetalis syndrome, where HBA1 and HBA2 genes 
are absent in both copies of chromosome 16, and therefore the fetus cannot synthesize 
α-globins to make HbF or HbA  (Jobling et al., 2013; Old, 2003b). 
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β-Thalassemias are a very heterogeneous group of disorders, with more than 200 
disease-causing mutations so far identified (Patrinos, 2004), including single nucleotide 
substitutions, and in a lower frequency than in α-thalassemias, insertions and deletions 
(Corrons, 2001; Old, 2003a). However, since many mutations are only prevalent in 
particular population groups, where the predominant ones account for the majority of 
mutation alleles and the less incidents are considered as rare mutations, at a worldwide 
scale only about 20 alleles account to the majority of all β-thalassemia (Kaushansky et 
al., 2010). 
 
1.3.2. Abnormal Hemoglobins 
More of 1000 Hb variants have been identified, arising as result of single nucleotide 
mutations affecting the α-, β-, δ- and ɣ-globin subunits, and therefore, modified HbA, 
HbA2 or HbF (Kaushansky et al., 2010; Old, 2003a). 
Depending on the hematological and/or clinical consequences, each variant can be 
sorted into different categories: variants that alter the hemoglobin physical/chemical 
properties; those from which result unstable proteins; others leading to Hb forms with 
altered oxygen affinity; M hemoglobins and variants that cause thalassemic phenotypes 
(Kaushansky et al., 2010). 
The modified hemoglobins that have been more frequently studied are HbS, HbC, 
HbE, HbDPunjab and HbOArab because of their clinical importance. HbS was the first to be 
identified at the molecular level by Pauling et al. (1949), who studied patients with Sickle 
Cell Disease (SCD), an anemia first reported in 1910 that is the most common of the 
severe structural Hb variants (Hoffbrand et al., 2010; Kaushansky et al., 2010) 
 
1.4. Sickle Cell Disease 
The sickle cell allele, HBB*S, characterized by the substitution of the nucleotide 
adenine by a thymine in the position 20 (c.20A>T) of the first exon of the HBB gene. This 
mutation leads to a β-globin chain where the amino-acid glutamic acid at position 6 is 
replaced by valine (β6Glu>Val) (Saiki et al., 1985). 
The most common sickle disorder is Sickle Cell Anemia (SCA), which arises when 
an individual carries two copies of the mutant gene, and consequently HbS (α2βS2) is the 
produced hemoglobin. The disease expression is due to the polymerization of 
deoxygenated hemoglobin S (Bridges and Pearson, 2008).  
In the pulmonary circulation, HbS molecules are in an oxygenated state because of 
the oxygen tension, presenting function and molecular structure similar to the HbA, and 
consequently erythrocytes display a typical conformation with a biconcave shape. 
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However, at the time of the release of the oxygen in the tissues, the protein undergoes 
a process of aggregation, resulting in filament structures consisting in linear polymers of 
HbS (Bridges and Pearson, 2008; Honig and Adams, 1986). 
The filaments are further organized into fibers that stretch and distort the erythrocytes 
membrane resulting in the characteristic sickle-shape. This structural modification 
decreases the flexibility of RBC that allows to pass through the capillaries into larger 
venules, resulting in microvascular occlusion that interrupts the blood flow (Bridges and 
Pearson, 2008; Honig and Adams, 1986; Kaushansky et al., 2010). 
Although the polymerization of hemoglobin doesn’t happen suddenly after 
deoxygenation, and therefore the erythrocytes can still enter the pulmonary circulation 
where they become again oxygenated, the repeated sickling cycles contributes to the 
premature destruction of the cells (Honig and Adams, 1986). 
Worldwide, >300 000 infants are born with SCA each year (Piel et al., 2013) and 
approximately 300 million people are heterozygous carriers of the mutation (HbAS). The 
heterozygous individuals are clinically described as having the Sickle Cell Trait, which, 
with rare exceptions, is asymptomatic (Kaushansky et al., 2010). 
 
1.4.1. Other Genotypes Underlying Sickle Cell Disease 
The coinheritance of HbS with other hemoglobin variant or β-thalassemias accounts 
for the remaining SCD, which encompass a number of sickling syndromes with clinical 
importance. The three most common are HbS/C (β6Glu>Val/β6Glu>Lys), which 
manifests with a moderate SCD phenotype, HbS/β+-thalassemia and HbS/β0-
thalassemia, which are two severe SCDs.  
HbC was the second variant to be described after HbS, and it is believed to have  
originated in the broad region encompassing Central West Africa and parts of West 
Africa, where it’s prevalence can reach 28%.(Kaushansky et al., 2010).  
Homozygous HBB*C do not suffer from vasoocclusion as HbS, but display a mild to 
moderate hemolytic anemia, not considered as a life-threatening disease, as a result of 
the formation of tetragonal crystals in erythrocytes. However the association of HbC and 
HbS prompts the reduced life expectancy of the double heterouzygous for both variants 
(Kaushansky et al., 2010; Vekilov, 2003).    
Due to the higher prevalence of HbSC individuals contrasting to HbC, it’s the reason 
why HbC is usual considered a sickle variant/disorder, even that those morphological 
events (polymerization of hemoglobin), are not associated to this variant. 
Among other rarer forms are included HbS/DPunjab (β6Glu>Val/β121Glu>Gln) and 
HbS/OArab (β6Glu>Val/β121Glu>Lys), both associated with severe phenotypes, or HbS/E 
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(β6Glu>Val/β26Glu>Lys), a SCD with mild clinical course (Bridges and Pearson, 2008; 
Kaushansky et al., 2010; Steinberg, 2009). 
 
1.4.2. The Malaria Hypothesis 
Although the majority of children born with SCA dies before the age of five due to the 
severity of the disease, still the frequencies of the HBB*S might reach remarkable high 
values in certain regions, contrary to what would be expected for genes under purifying 
selection (Piel et al., 2010). Haldane (1949) was the first to purpose an explanation to 
the paradoxical observations, suggesting that heterozygotes carriers of the HBB*S have 
protection against severe malaria, as soon would be sustained by the epidemiological 
works performed by Allison (1954). 
Since then, growing evidence for the correlation between Sickle Cell Disease and 
protection against the Plasmodium falciparum infection prompted numerous studies in 
order to analyze the distribution of the SCD in the world that ultimately would lead to 
formulate “The Malaria Hypothesis” (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence supporting such theory came from many studies. Besides the similarity of 
the distribution of malaria and HbS at local, regional and global scales, other evidence 
Figure 3 - Global distribution of HBB*S (a) and Malaria (b) (adapted from Rees et al. (2010)). 
a 
b 
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was provided by clinical studies in endemic malaria regions and by a number of in-vivo 
and ex-vivo studies (Williams and Weatherall, 2012).  
The sickle cell allele is widely distributed throughout sub-Saharan Africa (especially 
in tropical ecozone), the Middle East and parts of the Indian sub-continent, where the 
prevalence can range from 5% to 40% (Kaushansky et al., 2010; Weatherall and Clegg, 
2001). Such geographical distribution have close resemblance to the prevalence of 
malaria cases, concerning which Africa accounts for 82% of the current world disease 
cases, and for 90% of world malaria deaths (Depetris‐Chauvin and Weil, 2016).  
As a result of migrations to western countries, SDC prevalence also increased in 
areas where malaria was not endemic (Kaushansky et al., 2010). 
In many populations, besides the pressure of balancing selection, the high frequency 
of consanguineous marriages is also an important factor accounting for the increased 
frequency of the mutated allele (Williams and Weatherall, 2012). 
In parallel with epidemiological studies, many investigations were undertaken in 
order to identify the exact mechanisms by which HBB*S provide protection against 
malaria. Although those mechanisms are not fully elucidated to the date, it is widely 
accepted that they probably includes both innate and immune-mediated mechanisms 
that induce increased phagocytosis of HbAS parasitized red blood cells (Luzzatto, 2012; 
Rees et al., 2010). 
 
1.4.3. βS - Globin Haplotypes and Evolution of the Sickle Cell 
Allele 
Through the years, haplotyping of variants from the beta-globin gene cluster has 
revealed to be increasingly useful, allowing to address questions from the field of 
populations genetics but also to predict the severity of some hemoglobinopathies, like 
the SCD (Vinson et al., 2004).  
It is estimated that human genomes differ one nucleotide every 1000-1500 bases. 
Those variations are called Single Nucleotide Polymorphisms (SNP’s) and can be 
classified according to i) the region where they are located, ii) their consequences, or iii) 
the level of evolutionary conservation whereby they can be conservative or 
nonconservative (Buckingham and Flaws, 2007). 
Groups of SNP’s in the same chromosome that are in strong linkage disequilibrium 
(LD) define the so called haplotypes. They are a combination of alleles at different loci 
that are inherited together, unless recombination occurs (Buckingham and Flaws, 2007).  
The first and still more conventional strategy used to identify haplotypes in the beta-
globin gene cluster relies in the study of the Restriction Fragment Length Polymorphisms 
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(RFLP), and consists in the detection of the number and size of DNA fragments that 
result after digestion with restriction enzymes (Buckingham and Flaws, 2007). Therefore, 
variations at different SNP’s can enable or prevent the recognition by specific enzymes, 
and as a consequence different patterns of restriction are associated to distinct 
haplotypes. 
The first DNA haplotype in the β-cluster was described by Kan and Dozy (1978), who 
found that a Hpa I cleavage site was strongly associated with the HBB*S. Further works 
allowed the identification of another SNP’s also in strong L.D. with the same allele, 
although only in some African populations (Pagnier et al., 1984). 
As new SNPs were discovered, extending the haplotypic background associated to 
HBB*S, it was possible to identify distinct haplotypes typically found in specific 
populations. Accordingly, the main haplotypes become commonly known as: Benin 
(BEN), Bantu/Central African Republic (CAR), Senegal (SEN), Cameroon (CAM) and 
Arab-Indian, with the last being confined to Eastern Saudi Arabia and the Indian 
subcontinent (Table 1) (Crawford et al., 2002; Vinson et al., 2004).  
When an haplotype doesn’t fit in any of the above described, it is considered an 
atypical haplotype (Leal et al., 2016). 
 
 
A few decades ago, the observation that the main HBB*S haplotypes were 
molecularly quite divergent while presenting a very well-defined geographic distribution 
(Figure 4), led to hypothesize that multiple HBB*S alleles were originated independently 
by recurrent mutation in the different regions where each haplotype is more prevalent 
(Kan and Dozy, 1980; Pagnier et al., 1984). 
However, the question that still does not have a conclusive answer is whether the 
sickle mutation had indeed a multicentric origin, having appeared independently in 
different chromosome backgrounds, or rather its presence in different regions is due to 
a single origin with subsequent spread of the mutation by population admixture and 
people migration into regions where malaria was endemic within or outside Africa 
(Bitoungui et al., 2015; Kulozik et al., 1986). 
 
Table 1 - Restriction patterns of HBB*S associated haplotypes (adapted from Bitoungui et al. (2015)). 
 
 
 
FCUP 
Screening of HBB gene mutations in population samples from Alentejo 
and implementation of a SNaPshot® based system for HBB*S haplotyping  
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In a seminal article of Livingstone (1958) a scenario was provided assuming a single 
origin of HBB*S in which balancing selection and gene flow alone could explain the 
current patterns of distribution of HBB*S in Africa, arguing that the spread of agriculture 
in the last few thousand years was responsible for the spread of the selective advantage 
of the sickle cell gene, and hence for the spread of the gene itself.  
Moreover, the striking features of the entire β-cluster, including the presence of a 
recombination hotspot and frequent events of interallelic gene conversion that are able 
to generate highly divergent HBB*S haplotypes (Zago et al., 2000), were claimed to 
refute the multiple origin hypothesis and instead sustain that more likely HBB*S arose 
through a single mutation (Fullerton et al., 1994).  
It was also proposed that a combination of recombination, gene mutation and/or 
conversion events is the best explanation for the origin of HBB*S (Antonarakis et al., 
1984).  
One of the weakest points of the multiple origin hypothesis is that it implies that 
several identical but independent mutations have occurred in a short period of time after 
the appearance of malaria in Africa, which seems unlikely given the low mutation rate of 
nuclear DNA (Currat et al., 2002). Despite that, the multicentric origin of HBB*S become 
indeed the most common view about the subject. Yet, it was not plenty sustained in a 
very recent comprehensive study addressing the global distribution of HBB*S 
haplotypes, leading the authors to emphasize that a careful reassessment of African 
HBB*S haplotypes is still needed to elucidate the evolutionary dynamics of the sickle 
allele, not discarding for now a single origin of the sickle mutation (Bitoungui et al., 2015).  
 
Cameroon 
Figure 4 – Haplotypes distribution in African continent (adapted from Rodriguez Romero et al. (1998)). 
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Regardless of the evolutionary mechanisms from which arose the HBB*S 
haplotypes, since the referred to as typical haplotypes present a remarkable geographic 
specificity, they can give important insights to trace many episodes of the demographic 
history of a population. 
In terms of clinical implications, some works emerged indicating that haplotypes of 
β-globin cluster might modify the severity of the Sickle Cell Disease. As a rule, carriers 
of HBB*S on Senegal and Arab-Indian haplotypes usually have high levels of fetal 
hemoglobin (> 15%) and concentration of Gɣ-globin chains. Because high concentrations 
of HbF dilute the amount of HbS and disrupts its polymerisation, carriers of Senegal and 
Arab-Indian haplotypes are associated to reduced severity of phenotypes of the disease 
(Leal et al., 2016; Steinberg, 2009) 
In opposition to the Senegal and Arab-Indian haplotypes, the Bantu/CAR was 
associated with decreased HbF levels (< 5%) and consequently with a severe SCD 
phenotype (Leal et al., 2016; Steinberg, 2009). 
Reportedly, carriers of Benin and Cameroon have an intermediate clinical course, 
showing levels of HbF between 5% and 15% (Leal et al., 2016). 
The relation between haplotypes and clinical severity, is basically dictated by HbF 
levels, which have been strongly associated with an specific polymorphism, the 
rs7482144, that in fact is a variant commonly used in the identification of the haplotypes. 
Nevertheless, other genetic modulatory elements of the level of fetal hemoglobin also 
exist, as indicates the variability in those levels among carriers of the same allele at that 
SNP (Steinberg, 2009). 
 
1.5. Sickle Cell Disease in Portugal 
While the high frequency of alleles responsible by SCD is largely explained by the 
selective advantage that carriers have in environments where falciparum malaria is 
endemic, due to the migration of peoples, those alleles might also become relatively 
common in areas where malaria is not endemic (Antonarakis et al., 1984; Kaushansky 
et al., 2010). 
However, in Portugal malaria was endemic until mid-last century, and only in 1973 
was considered eradicated by the World Health Organization after extensive campaigns 
for disease control (Bruce-Chwatt and de Zulueta, 1977; Landeiro, 1933). 
Before the 1950s, estimates of 100,000 cases per year were usual, though unevenly 
distributed across the country (Landeiro, 1933). Then, several malariologic regions were 
documented, revealing different levels of endemicity. Among the regions with highest 
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incidence, was Alentejo/Ribatejo and the basins of the Tagus and Sado rivers where rice 
culture was a traditional activity (Bruce-Chwatt and de Zulueta, 1977). 
Is in those regions where malaria used to be a serious health problem, that HBB*S 
reaches the highest values in the country. Since long that those regions were very 
scarcely populated, and in order to cope with the needs to work in the swampy rice fields 
on the banks of southern rivers, many African slaves were brought to the region, which 
partially explain the distribution of the Sickle Cell Trait in the region (Gallup and Sachs, 
2001; Martins et al., 1993; Monteiro et al., 1989). 
Much before, contacts with Mediterranean people who have settled in different areas 
across south Portugal due to the better conditions for agriculture, fishing and mining, 
might have also contributed to the introduction of hemoglobin variants in Portugal 
(Martins et al., 1993). 
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2. Objectives 
 
In the present study it was intended the analysis of samples collected in Health Care 
Centers in Alentejo region in order to access the incidence of β-globin variants HBB*S 
and HBB*C, and the haplotypes distribution associated to the variants. 
 
For the purpose, the following objectives were settled:  
 Screening of sickle cell variants in samples from Coruche, Serpa and Alcácer 
do Sal; 
 Identification of Single Nucleotide Polymorphisms associated to the main 
sickle cell haplotypes; 
 Design of a new method for analysis of haplotypes associated to 
chromosomes with the sickle cell variations, based on an Multiplex 
SNaPshot® system; 
 Inference of haplotypes in HBB*S bearing individuals; 
 Comparison of the results with previous data regarding the incidence of Sickle 
Cell Disease (SCD) in Portugal and associated haplotypes. 
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3. Methodology 
3.1. Sampling 
In the present study, 266 blood samples previous collected in Health Care Centres 
from the Alentejo region (Portugal) were used to perform the screening of HBB gene 
mutations and subsequent identification of haplotypes associated to the variants. The 
samples belonged to unrelated individuals who had provided inform consent to 
participate in the study, allowing research use of their data. Out of them, 35 resided in 
Alcácer do Sal (Setúbal district), 71 in Serpa (Beja district) and 160 in Coruche 
(Santarém district). 
 
3.2. Sickle Cell Variants Screening 
3.2.1. DNA extraction 
Genomic DNA was extracted and purified from dried blood stains collected on FTA® 
cards (Whatman®), using QIAamp® DNA Investigator Kit by QIAGEN® following the 
manufacture´s protocol. 
 
3.2.2. PCR 
In order to identify sickle cell mutations, the HBB genic region encompassing the 
sequence where the variants are located (chromosome 11:5227110-5226531) was 
amplified by Polymerase Chain Reaction (PCR), for which a pair of primers was selected 
flanking the region.  
The two primers (Table 2) were designed according to the reference sequence of the 
HBB nucleotide (NM_000518) available in the platform Ensembl (Yates et al., 2015), 
after which their properties, like melting temperature, GC-content and self-
complementarity, were analysed in the platform Primer3 (Untergasser et al., 2012). 
Then, the platform UCSC Genome Browser – Blat (Kent, 2002) available 
in  http://genome.ucsc.edu/ was used to confirm the specificity of binding to the target 
genomic region. 
 
Table 2 - Primers for amplification of the target region of HBB gene and expected fragment size. 
Primer Sequence (5’>3’) Fragment Length (bp) 
HBB_FW AGCAGGGAGGGCAGGAGCCAG 
580 
HBB_RV  CCCCTTCCTATGACATGAACTTAACC 
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PCR reactions were prepared using 5 µL of HotStarTaq® Master Mix Kit (QIAGEN®), 
0.5 µL of each primer (2 µM), 1 µL of Q-Solution (QIAGEN®) (final concentration 10%) 
and 3 µL of DNA, making a total of 10 µL per reaction. The control reactions were 
performed by substituting de DNA with distilled water (RNase/DNase/Protease free). 
Amplification was conducted in a GeneAmp® PCR System 2700 (Applied 
Biosystems™) under the conditions presented in Table 3. 
 
Table 3 - PCR protocol for amplification of the target region of HBB gene. 
Step Temperature (ºC) Time Cycles 
Initial Denaturation 95 15 min 1 
Denaturation 94 30 sec  
Annealing 65 1:30 min 10 
Extension 72 1 min  
Denaturation 94 30 sec  
Annealing 62 1:30 min 30 
Extension 72 1 min  
Final Extension 70 10 min 1 
Hold 4 ∞ 
 
Amplification products were separated by horizontal polyacrylamide gel (8.4%) 
electrophoresis using a Multiphor II Electrophoresis System (GE Healthcare), with 
MultiTemp III Thermostatic Circulator (Amersham Biosciences) and Consort EV243 
power supply. The running was performed at 180V with 0’GeneRuler 100 bp Plus DNA 
Ladder (Thermo Scientific™) and the results were visualized by silver staining method, 
with the following sequential steps: 10 minutes in Ethanol (10%); 5 minutes in Nitric Acid 
(1%); two washings with distilled water; 20 minutes in Silver Nitrate; two washings with 
distilled water; DNA visualization with solution made with 3g Sodium Carbonate (0.28M) 
+ 1 mL Formaldehyde (0,02%) + 100 mL water; reaction termination with Acid Acetic 
(10%) and final washing with distilled water.  
 
3.2.3. Automated DNA Sequencing 
The amplified PCR products were submitted to purification by Sephadex™ G-50 Fine 
DNA Grade (GE Healthcare) gel filtration resin (following manufacture’s protocol for 
columns preparation) and subsequently used in sequencing reactions. In each reaction 
it was used 2 µL of BigDye™ Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems™) (previously diluted 1:2 with Buffer by Applied Biosystems™), 0.5 µL of 
HBB_FW primer and 2.5 µL of the purified product. 
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The PCR reaction was performed in GeneAmp® PCR System 2700 (Applied 
Biosystems™) under the conditions presented in Table 4. 
Fragments were analysed in an ABI PRISM 3130xl analyser (Applied Biosystems™) 
after purification with Sephadex™ G-50 (GE Healthcare)  gel filtration resin and posterior 
addition of 10 µL of Hi-Di™ Formamide (Applied Biosystems™). Sequences were 
aligned and analysed using Geneious v.5.5 analysis software (Biomatters, available from 
http://www.geneious.com/). 
 
Table 4 - PCR protocol for sequencing of the amplified target region of HBB gene. 
Step Temperature (ºC) Time Cycles 
Initial 
Denaturation 
96 2 min 1 
t r ti  96 15 sec  
Annealing 58 10 sec 35 
Extension 60 2 min  
Final Extension 60 10 min 1 
Hold 4 ∞ 
 
3.3. Genotyping of SNPs Defining Haplotypes 
3.3.1. Selection of SNPs 
A comprehensive bibliographic research about the haplotypes associated to the 
sickle cell mutation(s) was performed in order to identify the single nucleotide 
polymorphisms (SNPs) to be examined with a new approach we sought to develop in 
this project that consisted in a SNaPshot® Multiplex system. 
For that purpose, a reference sequence of the β-cluster was created using the 
platform Ensembl (Yates et al., 2015), comprising the nucleotide sequences of the genes 
HBE1, HBG2, HBG1, HBBP1, HBD and HBB (11:5271844 – 11:5222404). Since the 
conventional methodology for the identification of HBB*S haplotypes relies in the 
analysis of Restriction Fragment Length Polymorphism (RFLP), for which the primers 
commonly used were often described, we have begun by identifying the sequences of 
the fragments that typically would be amplified to be submitted to restriction enzymes 
digestion. Next, and given that the widely used restriction enzymes were also known, the 
exact location of the most informative polymorphisms defining the haplotypes were 
determined, ending up with a total of 6 SNPs: rs7482144, rs113425530, rs2070972, 
rs10128556, rs968857 and rs16911905 (Figure 5). 
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3.3.2. Multiplex PCR 
 Five pairs of new primers were designed in order to amplify the fragments containing 
the 6 target SNPs (Table 5) . In order to implement a Multiplex PCR, primers for 
amplification of fragments with different lengths were chosen with the assistance of 
platforms Primer3 (Untergasser et al., 2012), UCSC Genome Browser – Blat (Kent, 
2002) and In-Silico PCR (both available in  http://genome.ucsc.edu/), and the AutoDimer 
software (available from 
http://www.cstl.nist.gov/div831/strbase/AutoDimerHomepage/AutoDimerProgramHome
page.htm). 
 
Table 5 – Primers for amplification of the target regions of β-globin cluster and expected fragment sizes. 
Primer Sequence (5’>3’) Fragment Length (bp) 
5’HBG2_FW ACAAGAAGGTGAAAAACGG 
772 
5’HBG2_RV CTTTATGGCATCTCCCAAG 
HBG2_FW GCTGCAAGAAGAACAACTACC 
400 
HBG2_RV GACAACCATGTGTGATCTCTTA 
HBBP1_FW CAGGATTCTTTGTTATGAGTGTT 
332 
HBBP1_RV CAAGCTGGACTTGCAGTAA 
3’HBBP1_FW GAGACCTAAACTGAGGAACCTT 
208 
3’HBBP1_RV CTTGATGGACCCTAACTGATATA 
5’HBB_FW GATCACGTTGGGAAGCTATA 
166 
5’HBB_RV AGGTCTTCTACTTGGCTCAGA 
 
PCR reactions were performed in a final volume of 10 µL, containing 5 µL of Qiagen® 
Multiplex PCR Kit, 1 µL of Primer Mix, 3.5 µL of distilled water (RNase/DNase/Protease 
free) and 0.5 µL of DNA, under the conditions presented in Table 6. The Primer Mix was 
Figure 5 – Representation of the β-globin cluster, the target regions to be amplified (rose squares) encompassing the 
positions of six polymorphisms that define the haplotypes associated to the sickle cell variant. 
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prepared with a final concentration of 2 µM for each primer. Reactions were conducted 
in GeneAmp® PCR System 2700 (Applied Biosystems™). 
Amplification products were separated by horizontal polyacrylamide gel (8.4%) 
electrophoresis, after which DNA was visualized by the silver staining method previous 
described in section 3.2.2.  
 
Table 6 – Multiplex PCR protocol for amplification of the target regions of β-globin cluster. 
Step Temperature (ºC) Time Cycles 
Initial Denaturation 95 15 min 1 
Denaturation 94 30 sec  
Annealing 60 1:30 min 35 
Extension 72 1 min  
Final Extension 72 10 min 1 
Hold 4 ∞ 
 
 
3.3.3. SNaPshot® 
For the sake of developing a SNaPshot® Multiplex system to determine 
simultaneously the genotypes of the 6 target SNPs, Single Base Extension (SBE) 
primers were designed with the assistance of the platforms already mentioned for the 
construction of other primers (section 3.3.2). The SBEs hybridize to the sequence 
immediately adjacent to the target nucleotide base, and for the separation of each primer 
by capillary electrophoresis, non-annealing tails with different sizes were added to each 
of the 6 SBE primers. The sequences of the primers are described in Table 7, as well 
are the possible nucleotides that will be added to the terminal 3’ end of each SBE 
depending on the genotypes at the different SNPs.  
 
Table 7 – Single Base Extension primers for the genotyping of the target polymorphisms. 
rs Polymorphism 
Detected 
Allele 
Sequence (5’>3’) 
7482144 G>A G/A GGTGGAGTTTAGCCAGG 
113425530 C>A G/T 
GTCGTGAAAGTCTGACAATTGATTCTGGG
TGGAA 
2070972 A>C A/C 
GACTAAACTAGGTGCCACGTCGTGAAAGT
CTGACAACCTCCAGATAACTACACACC 
10128556 C>T G/A GTCTGACAATGTTGGGGTAGTGAGTTG 
968857 T>C T/C CAATGCATGACACATGCTTG 
16911905 G>C G/C 
TGCCACGTCGTGAAAGTCTGACAACGTTT
TAAAATCATTTCCTT 
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A purification step was performed in order to optimize the samples for the SNaPshot® 
reactions. It consisted in adding to each 1 µL of amplification product, 0.5 µL of ExoSAP-
IT™ (Applied Biosystems™), and then the solution was submitted to the conditions 
presented in Table 8 - Purification 1. 
After that, to each purified sample (1.5 µL), 1 µL of SNaPshot™ Multiplex Kit (Applied 
Biosystems™), 1 µL of SBE primer Mix, and 1.5 µL of distilled water 
(RNase/DNase/Protease free) was added. The SBE primer Mix was prepared in order 
to obtain the following concentrations in the final solution (5 µL): rs7482144 at 0.8 µM, 
rs113425530 at 1.4 µM, rs2070972 at 0.8 µM, rs10128556 at 0.3 µM, rs968857 at 0.6 
µM and rs16911905 at 0.6 µM. The SNaPshot® reactions were performed under the 
conditions described in Table 8 – SNaPshot®. 
A final purification step (Table 8 - Purification 2) was performed by adding up 1 µL of 
FastAP (Thermo Scientific™) to the final product.  
All the described reactions were conducted in GeneAmp® PCR System 2700 
(Applied Biosystems™). 
  
Table 8 – Protocols for the purification steps and genotyping of the target polymorphisms. 
Purification 1  SNaPshot®  Purification 2 
Temperature (ºC) Time  Temperature (ºC) Time  Temperature (ºC) Time 
37 15 min  96 10 sec  37 1 h 
85 15 min  50 5 sec  85 15 min 
   60 30 sec    
   25 cycles    
 
In order to be analyzed by capillary electrophoresis in an ABI PRISM 3130xl analyser 
(Applied Biosystems™), 1 µL of the SNaPshot® purified products were mixed with 12 µL 
of Hi-Di™ Formamide (Applied Biosystems™) and GeneScan™ – 120 LIZ™  Size 
Standard (Applied Biosystems™). The results were analyzed with the GeneMapper® 
v.4.0 software. 
 
3.4. Haplotype Determination 
Haplotype inference and Hardy-Weinberg equilibrium tests were performed with the 
Arlequin 3.5v software (Excoffier and Lischer, 2010).   
The correspondence here assumed between detected haplotypes and the commonly 
referred to as Bantu, Benin, Senegal, Arab-Indian and Cameroon haplotypes, is 
summarized in Table 9. 
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Both rs113425530 and rs2070972 are positioned in the same restriction enzyme 
recognition site when RFLP analysis is performed, therefore the genotypes of the two 
variants should be analyzed as a single result. The presence of nucleotide T in the first 
SNP or C in the second (where the presence of just one of them would be associated to 
the non-recognition by the restriction enzyme), should be linked to the Benin haplotype 
and consequently three genotypes can be associated to the same. 
 
Table 9 – Single Nucleotide Polymorphisms alleles associated to the main sickle cell haplotypes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 rs7482144 rs113425530 rs2070972 rs10128556 rs968857 rs16911905 
Bantu/CAR G G A G C C 
 G T C G T C 
Benin G T A G T C 
 G G C G T C 
Senegal A G A A T G 
Arab-Indian A G A A T C 
Cameroon G G A G T G 
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4. Results and Discussion 
4.1. Genotyping 
4.1.1. Sickle Cell Variants 
In this work, three population samples from Alcácer do Sal, Coruche and Serpa were 
addressed. The demographic characterization of the studied populations is summarized 
in Table 10, and more detailed information is presented in Table S1. 
 
Table 10 – Overall characteristics of the studied populations. 
Location Gender n Birth Year 
Alcácer do Sal 
(Setúbal) 
Male 13 1933-2001 
Female 22 1932-1987 
Serpa 
(Beja) 
Male 68 1917-2005 
Female 3 1927-1987 
Coruche 
(Santarém) 
Male 160 1918-2006 
Female 0 - 
 
 
Samples had been randomly collected among the users of the Health Care Centers 
from Alcácer do Sal, Coruche and Serpa. No inclusion criterion regarding health status 
was applied, meaning, thus, that patients with hemoglobinopathies were not deliberately 
included nor exclude from the study. However, three of the 35 individuals from Alcácer 
do Sal and nine of a total of 71 from Serpa were already referenced in the respective 
centers as having sickle cell trait/anemia.  
Sampling had been carried out in the scope of a FCT funded Project - Deciphering 
the origin of foci of high prevalence of hereditary anemias in Portugal: epidemiological 
and evolutionary study - POCI/ANT/57037, that involved the genetic characterization of 
the three populations with lineage markers (i.e. mitochondrial DNA and Y-chromosome). 
For that reason, sampling of male individuals had been prioritized, a recommendation 
that was strictly followed in Coruche. For that reason, males are clearly overrepresented 
on the whole of the three samples here analysed. 
From a total of 266 samples screened for HBB, 19 were positive for the presence of 
the c.20A>T mutation, corresponding to the single nucleotide polymorphism rs334 that 
define allele HBB*S (βS) (Figure 6). Two subjects from Alcácer do Sal, nine from Serpa 
and seven from Coruche, giving a total of 18 individuals, displayed the allele in 
heterozygosity, being therefore carriers of Sickle Cell Trait, whereas one subject from 
Serpa was homozygous, harbouring thus Sickle Cell Anemia. The observed genotypic 
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distributions and frequency estimates of βS in the three samples are presented in Table 
11. 
 
 
 
 
 
 
 
 
 
 
 
The two heterozygous from Alcácer do Sal corresponded to the subjects already 
diagnosed with Sickle Cell Trait. Among the nine subjects from Serpa with information of 
having Sickle Cell Trait/Anemia, eight were found to be heterozygous HbAS and one 
homozygous HbS. Additionally in the total sample from Serpa, another HbAS subject 
was detected who had no indication of being sickle cell carrier. 
 
Table 11 – Globin genotypes of the studied samples and frequencies of each genotype and βS allele in the different 
districts of Alentejo region. 
Location 
Globin 
Genotype 
n 
Globin Genotype 
Frequency (%) 
βS allele 
Frequency (%) 
Alcácer do Sal 
(Setúbal) 
AA 33 94.3 
2.9 
AS 2 5.7 
     
Serpa 
(Beja) 
AA 61 85.9 
7.7 AS 9 12.7 
SS 1 1.4 
     Coruche 
(Santarém) 
AA 153 95.6 
2.2 
AS 7 4.4 
     
Alentejo 
(all districts considered) 
AA 247 92.8 
3.8 AS 18 6.8 
SS 1 0.4 
 
The HBB*C mutation, which results from the missense variant c.19G>A 
(rs33930165) was not detected in any of the screened individuals. 
One of the most comprehensive studies regarding the prevalence of Hb disorders in 
Portugal dates back from 1993 (Martins et al.). Then, 15208 samples from the entire 
11:5226992 
11:5227011 11:5226992 
11:5226992 11:5227011 
11:5227011 
Figure 6 - Example of sequencing results in sickle variants screening; c.20A>T mutation represented on position 10 of 
the electropherogram. a – AA; b – AS; c – SS. 
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country where analysed and the results were presented considering a geographical 
distribution by administrative districts. In Portugal as a whole, the frequency of the Sickle 
Cell Trait was reported to be 0.32%, but its prevalence clearly increased from the north 
towards the south. In the north, the Sickle Cell Trait was not detected in the districts of 
Braga, Bragança, Viana do Castelo, Vila Real and Viseu, and only in Porto was found at 
very low prevalence of 0.05%. Contrarily, the districts of Beja, Setúbal and Santarém 
presented the highest values of 1.11%, 0.99% and 0.71% respectively, the latter ex-quo 
with Évora, while in Faro the frequency of HBB*S carriers was 0.68%. 
Much more recently, a project was conducted involving the screening of 
hemoglobinopathies only in the centre regions of Portugal, reinforced that in central 
Portugal the frequency of HBB*S was 0.22%, which is an intermediate value between 
those common in North and South of the country (Campos, 2007). 
In the light of this data, the proportion here estimated of heterozygous carriers of 
HBB*S either in Alcácer do Sal, from the Setúbal district, 5.7%, Coruche from the 
Santarém district, 4.4%, or Serpa from the Beja district, 12.7%, is remarkably higher than 
found in Martins et al. (1993) work. Actually, however, the discrepancy was not 
unexpected . First because samples from this study are not representative of the entire 
districts, but instead just encompass specific sub-regions within each one, contrarily to 
the study of Martins et al. (1993), which had a wider coverage in terms of geographic 
area and so naturally in terms of samples sizes. Second, and more importantly, because 
the samples here analysed were deliberately collected in sub-regions known to be foci 
of sickle cell carriers, as already highlighted in Martins et al. (1993) (though not 
discriminating the data for those foci), or before in Monteiro et al. (1989), who restrictively 
surveyed Coruche, where 8.2% heterozygous HbAS were found out, leading to estimate 
at 4.1% the frequency of HBB*S. 
Thus, the results here obtained are not only in agreement with the described in 
literature, but also shows that in 2007, the year during which most samples examined in 
this work were collected, Alcácer do Sal, Coruche and Serpa continued to be hot spots 
of HBB*S frequency, meaning thus that at least between 1989 and 2007, the genetic 
epidemiology of Sickle Cell Trait/Anemia did not changed substantially in the South of 
Portugal. 
In Serpa, the frequency of HBB*S reached the highest frequency, attaining the very 
unusual value of 7.7%. Besides the elevated proportion of heterozygous (12.7%), it was 
from Serpa the unique homozygous HbS detected in this study, accounting to 1.4% of 
the sample. In the absence of further published data for Serpa, it is impossible to evaluate 
the consistency of the data now obtained. However, we cannot exclude that the high 
frequency might had been inflated, in a certain extent, by some bias in the sampling 
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process. In fact, in that sample were only enrolled subjects from Pias, which is a very 
small parish from Serpa, being likely therefore that many related individuals live there.  
Tests of Hardy-Weinberg Equilibrium (HWE) performed for rs334 variant in the three 
population samples here analysed, did not revealed any significant  departures from the 
HWE expectations (Table 12). 
 
Table 12 - Hardy-Weinberg test results of polymorphism rs334 in Alcácer do Sal, Serpa and Coruche. 
Polymorphism Location 
Observed 
Heterozygosity 
Expected 
Heterozygosity 
p - value s. d. 
 Alcácer do Sal 0.05714 0.05631 1.00000 0.00000 
rs334 Serpa 0.12676 0.14394 0.34121 0.00050 
 Coruche 0.04372 0.04293 1.00000 0.00000 
 
 
4.1.2. Other Polymorphisms 
The primers designed flanking the first and second exons of HBB gene, allowed to 
examine the entire amplified region, encompassing exon 1 to the beginning of intron 
(IVS; InterVening Sequencing) 2, where it was possible to detect other polymorphisms 
besides the ones responsible for the HbS and HbC variants (Figure 7). 
 
Two of those polymorphisms were the c.9T>C and c.315+16G>C, corresponding to 
the SNPs rs713040 and rs10768683 respectively. Both were already contained in the 
HbVar database (Patrinos, 2004) under the category “rare variants”, without indication 
of any associated repercussion. The first one is a synonymous mutation, not implying 
any amino-acid change. The second one is located in the second intron of the HBB gene, 
to wich no clinical consequences are associated according to HbVar, and not leading to 
any splice alteration as predicted by ESEfinder v.3.0 (Smith et al., 2006).  
In the three population samples here analysed, it caught attention the strong relation 
between the two polymorphisms, since the presence of one allele at one SNP 
Figure 7 - Representation of HBB gene and position of the detected polymorphisms besides rs334. 
 
 
 
    
FCUP 
Screening of HBB gene mutations in population samples from Alentejo 
and implementation of a SNaPshot® based system for HBB*S haplotyping  
27 
determined the presence of the allele at the other SNP, in such a way that all 
homozygous for the derived variant at one SNP were also homozygous for the derived 
variant at the second, and heterozygous or homozygous to the ancestral alleles 
displayed identical correlation. The two SNPs were therefore submitted to the analysis 
of Linkage Disequilibrium (L.D.), which is the non-random association of alleles at 
different loci, having revealed to be in total L.D. (r2= 100%). 
Regarding the genotypic distribution, in the pooled samples, 2.6% were homozygous 
TT at rs713040 and GG at rs10768683, 20.3% heterozygous at both SNPs and 77.1% 
homozygous CC also at the two SNPs. Gene frequency of the minor allele at each loci 
was 0.128, which is similar to the values found among the European populations from 
the 1000 genomes Phase 3 (0.131-0.227) (Yates et al., 2015). 
Two other SNPs, rs368604295 and rs33935983, were both found in one 
heterozygous sample each. None was contained in HbVar (Patrinos, 2004). The first is 
a variant within the second intron (c.315+26T>G) that not interferes with mRNA splicing, 
according to the predictions in ESEfinder v.3.0 web resource (Smith et al., 2006) so 
without any consequences for the normal production of the β-globin subunits. The 
second is a missense variant in the second exon (c.169G>A), which results in the 
substitution of amino-acid glycine to serine in translation. Although the final product will 
be different, the variation does not affect the structure or function of the protein according 
to PolyPhen (Adzhubei et al., 2010) predictions, that scored the polymorphism as benign 
and therefore no clinical consequences are expected (Yates et al., 2015).  
In addition, two polymorphisms with clinical relevance were found in this study: the 
rs35004220/HbVar.827 (IVS I-110 (G>A)) and the rs11549407/HbVar.845 (CD39 (C>T)), 
detected in two and five heterozygous individuals, respectively (Figure 8). The two 
heterozygous for HbVar.827 were from Coruche, whereas among the heterozygous for 
HbVar.845, one was from Alcácer (actually the subject was referenced as possible 
HBB*S carrier) one from Serpa and three from Coruche. None of these seven individuals 
harboured sickle cell mutations.  
Both HbVar.827 and HbVar.845 result in a phenotype of thalassemia however with 
different characteristics. 
The variation at SNP rs35004220 is associated with β+-thalassemia, where the 
production of the protein is still active but in lower concentrations. Reportedly, the 
mutation is responsible for the creation of a new splice site that leads to production of 
about 90% of abnormally spliced mRNA, while only 10% of the mRNA is normal 
(Campos, 2007). 
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Although this mutation has a wide ethnic distribution, it is one of the most common 
β-thalassemia variants in the Mediterranean countries, representing 8.57% of β-
thalassemia variants in Portugal (Patrinos, 2004). 
The HbVar.845 is responsible by a β0-thalassemia phenotype, where the production 
of β-globin is completely abolished. This mutation causes the substitution of codon 39 
by a premature STOP codon, with subsequent termination of the mRNA translation.  
Similarly to the other detected β-thalassemia variant, also HbVar.845 was found to 
be present in various ethnics backgrounds, but its prevalence is highest in populations 
from the Mediterranean regions, including Portugal where it accounts to over one-third 
of β-thalassemia variants (Almeida, 2015; Patrinos, 2004).  
Former studies were conducted addressing β-thalassemias in Portugal, although the 
most recent published data regarding the south districts of the country are from the 90’s 
of the last century (Faustino et al., 1999; Martins et al., 1993; Ribeiro et al., 1997). The 
panorama for the centre of Portugal was updated in 2007 with the study of Campos 
(2007). 
According to Ribeiro et al. (1997), the reported contribution of five different mutations 
for the thalassemia phenotype in the south of Portugal was: IVS I-1 (G>A) 52.7%, CD39 
(C>T) 30.6%, IVS I-110 (G>A) 8.3%, IVS I-6 (T>C) 2.8% and CD15 (TGG>TGA) 2.8%. 
The results here obtained meet these data in the sense that the two identified 
thalassemia mutation are among the most common in South Portugal. However, 
contrarily to the findings of Ribeiro et al. (1997), the IVS I-1 (G>A) mutation, refereed as 
the commonest in their work, was not detected in any of the samples here analysed. 
Figure 8 - Examples of β-thalassemias screening results. a – Homozygous G/G; b – Heterozygous HbVar.827; c – 
Homozygous C/C ; d – Heterozygous HbVar.845. 
11:5226829 11:5226810 
11:5226829 
11:5226783 
11:5226783 
11:5226810 
11:5226764 
11:5226764 
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Even though it was not possible to analyse the entire HBB gene, essentially due to 
time limitations, the results obtained already afford an important view on the contribution 
of thalassemias to the burden of hemoglobinopathies in the south of country. 
 
 
 
4.2. SNP Genotyping 
The implementation of a new method for analysis of haplotypic data associated to 
the sickle cell HBB*S variant was one of the principal aims of the project, since to the 
date, such studies were performed primarily by Restriction Fragment Length 
Polymorphism analysis. Although a similar approach had already been applied, the 
number of polymorphisms analysed in Multiplex system was too low, which highly limited 
the haplotyping resolution (Crawford et al., 2002). 
After a throughout compilation of published studies regarding the SNPs in L.D. with 
the sickle cell allele, a primarily selection of the most relevant was performed. The criteria 
for choosing the polymorphisms was in order to permit the analysis of the minimum 
number of variants without losing the ability to identify unambiguously the associated 
sickle cell haplotypes. 
Among the initially selected SNPs, it was included a SNP located in HBG1 (Aɣ) gene, 
once it could provide some supplementary information for the haplotyping. However due 
to the high homology between HBG1 (Aɣ) and HBG2 (Gɣ), a gene that also contained 
other of the targets SNPs, it was not possible to design an SNaPshot® system that would 
differentiate the polymorphisms of both genes. For that reason, the less informative of 
the two SNPs, precisely that within HBG1, was not included in the Multiplex system.  
The main obstacle to implement the planned strategy allowing the study of the entire 
range of SNPs that define the HBB*S haplotypes, was the homology between the genes 
in the β-cluster, and consequently, the design of primers specifically to the target 
variations. Even though, such challenge was finally overcome and the SNaPshot® 
Multiplex technique was successfully developed for the simultaneous screening of the 
following 6 SNPs: rs7482144, rs113425530, rs2070972, rs10128556, rs968857 and 
rs16911905. A representative result of the Multiplex PCR and the SNaPshot® results of 
two unrelated individuals are illustrated in Figure 9 and Figure 10 respectively. 
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To achieve clear genotyping results as displayed in Figure 10, the steps that precede 
the SnaPshot® reaction are critical, specifically the amplification of the DNA fragments 
by Multiplex PCR. An insufficient genome amplification will affect later the efficacy of the 
SNaPshot® step, and thus particular attention was given to optimize the system of 6-plex 
multiplex. 
All samples with positive result for the presence of the c.20A>T mutation were 
submitted to the developed approach. The genotyping results are presented in Table 13. 
 
 
a 
b 
Figure 10 - Electropherograms examples of SnaPshot® reaction results and prediction of genotypes associated to each 
variants. a – sample SH/08; b – sample SH/07. 
Figure 9 – Multiplex PCR products; L – Ladder; 1 – 5’HBG2 Control; 2,3 – 5’HBG2; 4 – HBG2 Control; 5,6 – HBG2; 7 – 
HBBP1 Control; 8,9 – HBBP1; 10 – 3’HBBP1 Control; 11,12 – 3’HBBP1; 13 – 5’HBB Control; 14,15 – 5’HBB; 16 – Multiplex 
PCR Control; 17,18 – Multiplex PCR. 
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Table 13 – Single Nucleotide Polymorphisms genotypes obtained through SNaPshot® reactions, in samples with the 
sickle cell variant. AH – Alcácer do Sal; SH/SC – Serpa; CC – Coruche. 
 Polymorphisms 
Sample ID rs7482144 rs113425530 rs2070972 rs10128556 rs968857 rs16911905 
AH/02 G/A G/G A/A G/A T/C G/C 
AH/03 G/A G/G A/A G/A T/C G/C 
SH/01 G/G G/T A/C G/G T/C G/C 
SH/02 G/G T/T A/A G/G T/T C/C 
SH/03 G/G T/T A/A G/G T/T G/C 
SH/04 G/G G/T A/C G/G T/C G/C 
SH/05 G/G G/T A/A G/G T/T G/C 
SH/06 G/G G/T A/C G/G T/C G/C 
SH/07 G/G G/T A/C G/G T/C G/C 
SH/08 G/A G/T A/A G/A T/T G/C 
SH/09 G/G G/T A/C G/G T/C G/C 
SC/60 G/A G/T A/A G/A T/T C/C 
CC/04 G/G G/G A/C G/G C/C G/C 
CC/09 G/A G/G A/C G/A T/C G/G 
CC/16 G/A G/G A/C G/A T/C G/G 
CC/24 G/A G/G A/C G/A T/C G/G 
CC/25 G/A G/G A/A A/A T/T G/G 
CC/45 G/G G/G A/A G/G T/C G/C 
CC/151 G/A G/G A/A G/A T/T G/G 
 
 
 
 
To evaluate the accuracy of the results provided by the technique, 16 samples 
previously haplotyped through conventional RFLP analysis in Instituto Nacional de 
Saúde Doutor Ricardo Jorge (INSA) were used as control. The control samples were 
from individual with Sickle Cell Disease, except P7, P8, P11, P15 and P16 that were 
carriers of two distinct hemoglobinopathies: Sickle Cell Trait and β-thalasemia. 
The genotypes here obtained by SNaPshot® Multiplex are presented in Table 14. 
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Table 14 - Single Nucleotide Polymorphisms genotypes obtained through SNaPshot® reactions, in 16 control samples. 
 Polymorphisms 
Sample ID rs7482144 rs113425530 rs2070972 rs10128556 rs968857 rs16911905 
P1 G/A G/G A/A G/A T/C G/C 
P2 G/A G/T A/A G/A T/T G/C 
P3 G/A G/T A/A G/A T/T G/C 
P4 G/A G/G A/A G/A T/C G/C 
P7 G/G G/G A/C G/G C/C G/C 
P8 G/G G/T A/A G/G T/T G/C 
P9 G/G G/G A/A G/G C/C C/C 
P10 G/A G/G A/A G/A T/C G/C 
P11 G/G G/G A/C G/G C/C G/C 
P12 G/G G/G A/A G/G C/C C/C 
P14 G/A G/G A/A G/A T/C G/C 
P15 G/G G/G A/C G/G C/C G/C 
P16 G/A G/G A/A G/A T/T G/C 
P17 G/G G/T A/A G/G T/C C/C 
P19 G/G T/T A/A G/G T/T C/C 
P21 G/G G/T A/A G/G T/C C/C 
 
 
In order to evaluate the strength of the association between the studied variants, 
Linkage Disequilibrium analysis was performed in the platform Ensembl (Yates et al., 
2015). As expected, the pairwise L.D. values were statistically significant in the 
populations from the 1000 genomes project with data available, as is summarized in 
Table 15. 
 
Table 15 – Linkage Disequilibrium (L.D.) results of the studied SNPs. (+) – Significant L.D.; nd – No data. 
 rs7482144 rs113425530 rs2070972 rs10128556 rs968857 rs16911905 rs334 
rs7482144 * nd nd nd nd nd nd 
rs113425530 nd * + + + + + 
rs2070972 nd + * + + + + 
rs10128556 nd + + * + + + 
rs968857 nd + + + * + + 
rs16911905 nd + + + + * + 
rs334 nd + + + + + * 
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4.3. βS-Globin Haplotypes 
From the raw genotypic data, haplotypes were estimated with the ELB algorithm 
implemented in Arlequin 3.5v software, which inferred a total of nine haplotypes in the 
samples from Alcácer, Coruche and Serpa harboring the sickle cell mutation (Table 16). 
Since those samples were heterozygous for the sickle cell mutation, except one that was 
homozygous, the genotypes for rs334 were also included in Arlequin input file, and 
therefore, the inferred haplotypes anchored in the HBB*S background were only 3: 
Haplotypes ID 2, 3 and 8, in Table 16. 
 
Table 16 – Inferred haplotypes associated to the 19 studied samples, by Arlequin 3.5v software, respectively frequency 
and identification of the main haplotype associated. Haplotypes defined by polymorphisms in the following order: 
rs7482144, rs113425530, rs2070972, rs10128556, rs968857, rs16911905 and rs334. 
Haplotype ID Haplotype Frequency Observations 
1 AGAATGA 0.078947  
2 GGAGCCT 0.105263 Haplotype Bantu 
3 GTAGTCT 0.289474 Haplotype Benin 
4 GGCGCGA 0.236842  
5 GTAGTGA 0.026316  
6 GGAGTGA 0.078947  
7 AGAATCA 0.026316  
8 AGAATGT 0.131579 Haplotype Senegal 
9 GGAATGA 0.026316  
 
 
 
According to the assumed correspondence with the conventional haplotype 
nomenclature (section 3.4 – Table 9), the inferred haplotypes 2, 3 and 8 matched the 
haplotypes Bantu, Benin and Senegal, respectively. None of the commonly referred as 
atypical haplotype was detected. 
Concerning the samples used as controls, that is, those in which haplotypes had 
been previously determined by RFLP typing, from the new genotypic data here obtained 
with the SNaPshot® system, haplotypes were also inferred as above mentioned, and the 
results are presented in Table 17. For all samples, the haplotypes inferred coincided with 
those based on RFPL analysis, an observation that clearly sustains the quality of the 
implemented SNaPshot® methodology. 
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Table 17 – HBB*S haplotypes associated to the control samples. T-Thalassemia. 
Sample ID HBB*S Haplotype 
P1 Senegal/Bantu 
P2 Senegal/Benin 
P3 Benin/Senegal 
P4 Bantu/Senegal 
P7 Bantu/T 
P8 Benin/T 
P9 Bantu/Bantu 
P10 Senegal/Bantu 
P11 Bantu/T 
P12 Bantu/Bantu 
P14 Bantu/Senegal 
P15 Bantu/T 
P16 Senegal/T 
P17 Bantu/Benin 
P19 Benin/Benin 
P21 Benin/Bantu 
 
 
Among the 19 individuals from Alcácer do Sal, Coruche and Serpa bearing the sickle 
cell gene, the Benin accounted to 29% of total haplotypes, the Senegal to 13.1%, and 
the Bantu to 10.5% (Table 18).  
In previous studies addressing HBB*S haplotypes in Portugal, also the Benin, the 
Bantu and the Senegal haplotypes were uniquely detected (Lavinha et al., 1992; 
Monteiro et al., 1989). 
However, an interesting finding in this study respects the distribution of HBB*S 
haplotypes in the three population samples: the Benin haplotype was uniquely detected 
in Serpa where no other haplotype was found among the 11 chromosomes harbouring 
HBB*S; the Senegal haplotype was only found in Coruche, in five out the seven HBB*S 
chromosomes; the remaining two haplotypes from Coruche were Bantu, as also were 
the two HBB*S chromosomes from Alcácer do Sal. This distribution suggest that the 
introduction of HBB*S in Serpa may have been due to an importation event distinct from 
that (or those) responsible by the presence of HBB*S in Alcácer and Coruche.      
In order to further explore this question, and given that the samples from Alcácer, 
Coruche and Serpa were previously characterised for mitochondrial DNA (mtDNA) and 
Y-chromosome lineages (Pereira et al. (2010)), the results on those markers were  
recruited for HBB*S haplotypes here identified (Table 18). 
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Table 18 – HBB*S, mitochondrial and Y-chromosome haplotypes associated to samples with rs334 variant. AH – Alcácer 
do Sal; SH/SC – Serpa; CC – Coruche; A – HbA; (-) – Female; nd – No data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Focusing on the mtDNA results because they are available for all the 19 individuals 
regardless their sex, (contrarily to Y-chromosome data, which obviously was only 
obtained for males), it is noteworthy the combined frequency of haplogroups I, J, and T 
among the HBB*S bearing chromosomes, all having the Benin haplotype as background. 
In the study of Pereira et al. (2010) a thin differentiation of Pias comparatively to Alcácer 
and Coruche was detected that was mainly attributed precisely to the global frequency 
of haplogroups I, J, and T in Pias. Since the three mtDNA haplogroups are typical from 
peri-Mediterranean populations, the authors proposed that Pias had retained a stronger 
link with Mediterraneans than other Portuguese populations.  
Coincidently, the Benin haplotype, which is the most prevalent HBB*S haplotypes at 
the worldwide level, reaches its highest frequency throughout all Mediterranean regions 
(Bitoungui et al., 2015).  
Sample 
ID 
HBB*S 
Haplotype 
mtDNA 
Haplotype 
Y-Cr 
Haplotype 
AH/02 Bantu/A U6b - 
AH/03 Bantu/A K1a E1b1b1b* 
SH/01 Benin/A H* - 
SH/02 Benin/Benin J1b1 R1b1* 
SH/03 Benin/A HV0 - 
SH/04 Benin/A I1a - 
SH/05 Benin/A T1 J* 
SH/06 Benin/A T1 nd 
SH/07 Benin/A T1 nd 
SH/08 Benin/A J1c1 P* 
SH/09 Benin/A J1c1 nd 
SC/60 Benin/A H2a R1b1* 
CC/04 Bantu/A K1a J2* 
CC/09 Senegal/A L1b nd 
CC/16 Senegal/A U5b R1b1* 
CC/24 Senegal/A H* E1b1b1b* 
CC/25 Senegal/A K1a E1b1b1b* 
CC/45 Bantu/A HV0 P* 
CC/151 Senegal/A U6a R1b1* 
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Thus, the Mediterranean influence in Pias seems now reinforced with the observation 
that the Benin haplotype is restrictively present in the region. 
In the HBB*S chromosomes from Alcácer (only two) and especially from Coruche 
(seven in total) the distribution of mtDNA lineages is less unusual in the context of the 
general Portuguese mtDNA diversity, excepting the presence of a L1b lineage in a sickle 
cell chromosome from Coruche (CC/09). The presence of mtDNA L lineages outside 
sub-Saharan Africa, where they are typically found, is mainly attributed to the influx of 
African lineages that occurred during the Atlantic slave trade, lasted from the mid-15th 
century until the late-18th century. In Portugal, and especially in the south, L lineages are 
considerably more common than in the rest of Europe, denoting the demographic impact 
of the presence of African slaves in the country. The detection that one individual from 
Coruche carrier of the sickle cell trait in a Senegal haplotype also bears an mtDNA 
lineage of sub-Saharan extraction, suggests that in Coruche, African slaves had an 
important role in the importation of the Sickle Cell Trait to the region. 
Furthermore, both the Senegal and the Bantu haplotypes found in Coruche, are very 
common in the regions from Africa that were main sources of slaves brought to Portugal.  
Whereas the Bantu haplotype attains the highest prevalence in Central, Southern, and 
East Africa, the Senegal haplotype is more restricted to the far west regions of Africa, 
where it peaks in frequency (Bitoungui et al., 2015) 
Globally, the results here obtained fully meet the picture proposed by Lavinha et al. 
(1992), positing that the Sickle Cell Trait might have been imported twice into Portugal: 
first,  between the eighth and the thirteenth centuries from the Mediterranean basin (in 
association with the Benin haplotype) and later, after the fifteenth century from sub-
Saharan Africa over an Atlantic route (Senegal and Bantu haplotypes).  
This two-step process of introduction of HBB*S was based on the observation in 
Portugal of a superposition of two Bantu-Senegal foci over a diffuse distribution of the 
Benin haplotype (Lavinha et al., 1992). In this study, two foci of Bantu-Senegal 
haplotypes were also detected (in Coruche and Alcácer do Sal), but the distribution of 
the Benin haplotype was not diffuse, since instead it was only present in Serpa (Pias). 
This late finding suggests that in Pias a founder effect might have underlain the high 
frequency of HBB*S in the current day population. 
Previous studies have provide evidence that HBB*S haplotypes are associated to 
levels of fetal hemoglobin, which is the best known modifier of the clinical features of 
SCD (Steinberg, 2009). According to those studies, the Senegal and Arab-Indian 
haplotypes correlate with high percentage of HbF and consequently with milder course 
of the disease, the Bantu/CAR is related to low levels of HbF and a more severe 
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phenotype, while the Benin haplotype is thought to confer a relatively favorable clinical 
outcome (Bitoungui et al., 2015; Steinberg, 2009) 
Since no hematological parameters or clinical data were available for the participants 
in this study, it was not possible to evaluate such correlation in the population samples 
analysed.  
However, the observation that the unique homozygous for HBB*S harboured two 
Benin haplotypes, and was a subject from Pias, a foci of HBB*S in the Benin haplotype 
where the allele reaches the very unusual frequency of 7,7%, seems consistent with the 
favorable clinical outcome to which the Benin haplotype is associated. Naturally, the 
issue still deserves future investigation. 
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5. Final Remarks  
The implemented SNaPshot® Multiplex methodology as proven to be an efficient 
technique to genotype the SNPs difining haplotypes associated to HBB*S. 
Comparatively to the conventional RFLP technique, the SNaPshot® strategy 
simplifies substantialy the inference of haplotypes. 
In that way it was possible to obtain a fine characterization of HBB*S allels in three 
regions of Alentejo that previously had been already reported as foci of high prevalence 
of the allele, although for Pias (Serpa) no published data was available to the date.  
The data presented here indicates that Pias may be the region where HBB*S reaches 
the highest frequency in Portugal (7.7%), while in Coruche and Alcácer do Sal the 
frequencies were 2.2% and 2.9% respectively, wich are both high values within the 
Portuguese context. 
Analysis of haplotypes was essential to obtain some insights on the introduction of 
HBB*S in Alentejo. The exclusive detection of Benin haplotype in Pias, whereas in 
Alcácer and Coruche this haplotype was absent but instead were present the Senegal 
and Bantu types, seems to be a clear sign that at least two migratory waves were 
responsible by the presence of the variant in Portugal: one coming from the region 
encompassing the Mediterranean basin (captured by the Benin haplotype), and other 
from sub-Saharan Africa, likely afforded by the transatlantic slave trade (captured by the 
Senegal and Bantu haplotypes). Remarkably, this scenario meets the picture proposed 
by Lavinha et al. (1992), despite the observed confinement of the Benin haplotype to 
Pias, wich suggest that a founder effect might be associated to the region. 
Along with HBB*S, two β-thalassemias variants were detected in seven individuals 
out of total 266, giving a frequency of 0.013, wich is also a rather high value.  
Globaly this study reinforce previous epidemiological data demonstrating that in 
south of Portugal hemoglobinopathies continue to be a serious concern in terms of health 
care. 
In the future it would be important to complete the screening of HBB, wich due to 
time limitations was not possible to do in this work, and to haplotype the β-thalassemia 
variants.  
More importantly, however, further studies should be done in order to obtain a picture 
still more detailed on the epidemiology of hemoglobinopathies in Portugal. 
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Supplementary Data 
Table S1 - Demographic characterization and genotypic data of the polymorphisms found in the studied samples. 
AH/AC – Alcácer do Sal; SH/SC – Serpa; CC – Coruche; F – Female; M – Male. 
   Polymorphisms     Polymorphisms 
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AH/01 F 48 A/A C/C C/C G/G C/T T/T G/G 
 
SC/13 M 44 A/A C/C C/C G/G C/C T/G G/G 
AH/02 F 60 A/T C/C C/C G/G C/C T/T G/G 
 
SC/14 M 83 A/A C/C C/C G/G C/C T/T G/G 
AH/03 M 16 A/T C/C C/C G/G C/C T/T G/G 
 
SC/15 M 12 A/A C/C C/C G/G C/C T/T G/G 
AC/01 F 65 A/A C/C C/C G/G C/C T/T G/G 
 
SC/16 M 50 A/A C/C C/C G/G C/C T/T G/G 
AC/02 F 66 A/A T/C G/C G/G C/C T/T G/G 
 
SC/17 M 94 A/A T/C G/C G/G C/C T/T G/G 
AC/03 F 77 A/A C/C C/C G/G C/C T/T G/G 
 
SC/18 M 85 A/A T/C G/C G/G C/C T/T G/G 
AC/04 F 58 A/A C/C C/C G/G C/C T/T G/G 
 
SC/19 M 12 A/A C/C C/C G/G C/C T/T G/G 
AC/05 F 31 A/A T/C G/C G/G C/C T/T G/G 
 
SC/20 M 89 A/A C/C C/C G/G C/C T/T G/G 
AC/06 F 64 A/A C/C C/C G/G C/C T/T G/G 
 
SC/21 M 78 A/A T/C G/C G/G C/C T/T G/G 
AC/07 F 59 A/A C/C C/C G/G C/C T/T G/G 
 
SC/22 M 78 A/A T/C G/C G/G C/C T/T G/G 
AC/08 M 77 A/A C/C C/C G/G C/C T/T G/G 
 
SC/23 M 78 A/A C/C C/C G/G C/C T/T G/G 
AC/09 M - A/A C/C C/C G/G C/C T/T G/G 
 
SC/24 M 86 A/A C/C C/C G/G C/C T/T G/G 
AC/10 M 72 A/A C/C C/C G/G C/C T/T G/G 
 
SC/25 M 83 A/A C/C C/C G/G C/C T/T G/G 
AC/11 M 75 A/A T/C G/C G/G C/C T/T G/G 
 
SC/26 M 97 A/A C/C C/C G/G C/C T/T G/G 
AC/12 M 65 A/A C/C C/C G/G C/C T/T G/G 
 
SC/27 M - A/A C/C C/C G/G C/C T/T G/G 
AC/13 M 57 A/A C/C C/C G/G C/C T/T G/G 
 
SC/28 M 78 A/A T/C G/C G/G C/C T/T G/G 
AC/14 F 39 A/A C/C C/C G/G C/C T/T G/G 
 
SC/29 M 82 A/A C/C C/C G/G C/C T/T G/G 
AC/15 F 46 A/A C/C C/C G/G C/C T/T G/G 
 
SC/30 M 81 A/A C/C C/C G/G C/C T/T G/G 
AC/16 F 80 A/A C/C C/C G/G C/C T/T G/G 
 
SC/31 M 83 A/A C/C C/C G/G C/C T/T G/G 
AC/17 M 61 A/A T/C G/C G/G C/C T/T G/G 
 
SC/32 M 66 A/A C/C C/C G/G C/C T/T G/G 
AC/18 F 42 A/A C/C C/C G/G C/C T/T G/G 
 
SC/33 M 86 A/A C/C C/C G/G C/C T/T G/G 
AC/19 M 84 A/A C/C C/C G/G C/C T/T G/G 
 
SC/34 M 88 A/A C/C C/C G/G C/C T/T G/G 
AC/20 F 46 A/A C/C C/C G/G C/C T/T G/G 
 
SC/35 M 92 A/A T/C G/C G/G C/C T/T G/G 
AC/21 F 70 A/A T/C G/C G/G C/C T/T G/G 
 
SC/36 M 35 A/A T/C G/C G/G C/C T/T G/G 
AC/22 F 69 A/A C/C C/C G/G C/C T/T G/G 
 
SC/37 M 82 A/A C/C C/C G/G C/C T/T G/G 
AC/23 F 60 A/A C/C C/C G/G C/C T/T G/G 
 
SC/38 M 90 A/A C/C C/C G/G C/C T/T G/G 
AC/24 F 30 A/A T/C G/C G/G C/C T/T G/G 
 
SC/39 M 70 A/A C/C C/C G/G C/C T/T G/G 
AC/25 M 64 A/A C/C C/C G/G C/C T/T G/G 
 
SC/40 M 54 A/A T/C G/C G/G C/C T/T G/G 
AC/26 F 85 A/A C/C C/C G/G C/C T/T G/G 
 
SC/41 M 65 A/A C/C C/C G/G C/C T/T G/G 
AC/27 M 67 A/A C/C C/C G/G C/C T/T G/G 
 
SC/42 M 67 A/A C/C C/C G/G C/C T/T G/G 
AC/28 M 72 A/A C/C C/C G/G C/C T/T G/G 
 
SC/43 M 77 A/A C/C C/C G/G C/T T/T G/G 
AC/29 F 69 A/A C/C C/C G/G C/C T/T G/G 
 
SC/45 M 84 A/A C/C C/C G/G C/C T/T G/G 
AC/30 F 60 A/A C/C C/C G/G C/C T/T G/G 
 
SC/48 M 89 A/A C/C C/C G/G C/C T/T G/G 
AC/31 F 78 A/A C/C C/C G/G C/C T/T G/G 
 
SC/49 M 28 A/A C/C C/C G/G C/C T/T G/G 
AC/32 M 82 A/A T/C G/C G/G C/C T/T G/G 
 
SC/51 M 80 A/A C/C C/C G/G C/C T/T G/G 
SH/01 F 42 A/T C/C C/C G/G C/C T/T G/G 
 
SC/52 M 71 A/A C/C C/C G/G C/C T/T G/G 
SH/02 M 36 T/T C/C C/C G/G C/C T/T G/G 
 
SC/53 M 74 A/A C/C C/C G/G C/C T/T G/G 
SH/03 F 30 A/T C/C C/C G/G C/C T/T G/G 
 
SC/54 M 84 A/A C/C C/C G/G C/C T/T G/G 
SH/04 F 90 A/T C/C C/C G/G C/C T/T G/G 
 
SC/55 M 45 A/A C/C C/C G/G C/C T/T G/G 
SH/05 M 37 A/T T/C G/C G/G C/C T/T G/G 
 
SC/56 M 59 A/A T/T G/G G/G C/C T/T G/G 
SH/06 M 99 A/T C/C C/C G/G C/C T/T G/G 
 
SC/57 M 51 A/A T/C G/C G/G C/C T/T G/G 
SH/07 M 61 A/T T/C G/C G/G C/C T/T G/G 
 
SC/58 M 79 A/A C/C C/C G/G C/C T/T G/G 
SH/08 M 100 A/T C/C C/C G/G C/C T/T G/G 
 
SC/59 M 86 A/A C/C C/C G/G C/C T/T G/G 
SH/09 M 79 A/T C/C C/C G/G C/C T/T G/G 
 
SC/60 M 86 A/T C/C C/C G/G C/C T/T G/G 
SC/01 M 82 A/A C/C C/C G/G C/C T/T G/G 
 
SC/61 M 86 A/A C/C C/C G/G C/C T/T G/G 
SC/02 M 85 A/A C/C C/C G/G C/C T/T G/G 
 
SC/62 M - A/A C/C C/C G/G C/C T/T G/G 
SC/03 M 83 A/A T/C G/C G/G C/C T/T G/G 
 
SC/63 M 57 A/A C/C C/C G/G C/C T/T G/G 
SC/04 M 86 A/A C/C C/C G/G C/C T/T G/G 
 
SC/64 M 82 A/A C/C C/C G/G C/C T/T G/G 
SC/05 M 97 A/A T/T G/G G/G C/C T/T G/G 
 
SC/65 M 86 A/A T/C G/C G/G C/C T/T G/G 
SC/06 M 79 A/A T/C G/C G/G C/C T/T G/G 
 
SC/66 M 54 A/A C/C C/C G/G C/C T/T G/G 
SC/07 M 91 A/A C/C C/C G/G C/C T/T G/G 
 
CC/01 M 78 A/A T/C G/C G/G C/C T/T G/G 
SC/08 M 78 A/A C/C C/C G/G C/C T/T G/G 
 
CC/02 M 78 A/A C/C C/C G/G C/C T/T G/G 
SC/09 M 85 A/A C/C C/C G/G C/C T/T G/G 
 
CC/03 M 92 A/A C/C C/C G/G C/C T/T G/G 
SC/10 M 33 A/A C/C C/C G/G C/C T/T G/G 
 
CC/04 M 88 A/T C/C C/C G/G C/C T/T G/G 
SC/11 M 40 A/A C/C C/C G/G C/C T/T G/G 
 
CC/05 M 78 A/A T/C G/C G/G C/C T/T G/G 
SC/12 M 12 A/A C/C C/C G/G C/C T/T G/G 
 
CC/06 M 51 A/A C/C C/C G/G C/C T/T G/G 
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CC/07 M 78 A/A C/C C/C G/G C/C T/T G/G 
 
CC/90 M 81 A/A T/C G/C G/G C/C T/T G/G 
CC/08 M 93 A/A C/C C/C G/G C/C T/T G/G 
 
CC/91 M 40 A/A C/C C/C G/G C/C T/T G/G 
CC/09 M 99 A/T C/C C/C G/G C/C T/T G/G 
 
CC/99 M 83 A/A T/T G/G G/G C/C T/T G/G 
CC/10 M 90 A/A C/C C/C G/G C/C T/T G/G 
 
CC/100 M 64 A/A C/C C/C G/G C/C T/T G/G 
CC/11 M 75 A/A C/C C/C G/G C/T T/T G/G 
 
CC/101 M 90 A/A C/C C/C G/G C/C T/T G/G 
CC/12 M - A/A T/C G/C G/G C/C T/T G/G 
 
CC/102 M 71 A/A C/C C/C G/G C/C T/T G/G 
CC/13 M 87 A/A C/C C/C G/G C/C T/T G/G 
 
CC/103 M 78 A/A T/C G/C G/G C/C T/T G/G 
CC/14 M 93 A/A C/C C/C G/G C/C T/T G/G 
 
CC/104 M 80 A/A C/C C/C G/G C/C T/T G/G 
CC/15 M 65 A/A T/C G/C G/G C/C T/T G/G 
 
CC/105 M 70 A/A T/T G/G G/G C/C T/T G/G 
CC/16 M 39 A/T C/C C/C G/G C/C T/T G/G 
 
CC/111 M 67 A/A C/C C/C G/G C/C T/T G/G 
CC/17 M 86 A/A C/C C/C G/G C/C T/T G/G 
 
CC/112 M 72 A/A C/C C/C G/G C/C T/T G/G 
CC/18 M 74 A/A C/C C/C G/G C/C T/T G/G 
 
CC/113 M 71 A/A C/C C/C G/G C/T T/T G/G 
CC/19 M 74 A/A C/C C/C G/G C/C T/T G/G 
 
CC/114 M 82 A/A T/C G/C G/G C/C T/T G/G 
CC/20 M 81 A/A C/C C/C G/G C/C T/T G/G 
 
CC/115 M 90 A/A C/C C/C G/G C/C T/T G/G 
CC/21 M - A/A C/C C/C G/G C/C T/T G/G 
 
CC/116 M 80 A/A T/C G/C G/G C/C T/T G/G 
CC/22 M 91 A/A C/C C/C G/G C/C T/T G/G 
 
CC/117 M 42 A/A C/C C/C G/G C/C T/T G/G 
CC/23 M 88 A/A C/C C/C G/G C/C T/T G/G 
 
CC/118 M 60 A/A T/T G/G G/G C/C T/T G/G 
CC/24 M 87 A/T C/C C/C G/G C/C T/T G/G 
 
CC/119 M 46 A/A T/C G/C G/G C/C T/T G/G 
CC/25 M 33 A/T T/C G/C G/G C/C T/T G/G 
 
CC/120 M 77 A/A C/C C/C G/G C/C T/T G/G 
CC/26 M 56 A/A C/C C/C G/G C/C T/T G/G 
 
CC/121 M 60 A/A C/C C/C G/G C/C T/T G/G 
CC/27 M 44 A/A C/C C/C G/G C/C T/T G/G 
 
CC/122 M 75 A/A C/C C/C G/G C/C T/T G/G 
CC/28 M 86 A/A C/C C/C G/G C/C T/T G/G 
 
CC/123 M 77 A/A T/C G/C G/G C/C T/T G/G 
CC/29 M 35 A/A C/C C/C G/G C/C T/T G/G 
 
CC/124 M 76 A/A T/C G/C G/G C/C T/T G/G 
CC/30 M 83 A/A T/C G/C G/A C/C T/T G/G 
 
CC/125 M 93 A/A C/C C/C G/G C/C T/T G/G 
CC/31 M 82 A/A C/C C/C G/G C/C T/T G/G 
 
CC/126 M 78 A/A C/C C/C G/G C/C T/T G/G 
CC/32 M 58 A/A C/C C/C G/G C/C T/T G/G 
 
CC/127 M 38 A/A C/C C/C G/G C/C T/T G/G 
CC/33 M 74 A/A C/C C/C G/G C/C T/T G/G 
 
CC/128 M 77 A/A C/C C/C G/G C/C T/T G/G 
CC/34 M 83 A/A C/C C/C G/G C/C T/T G/G 
 
CC/129 M 80 A/A C/C C/C G/G C/C T/T G/G 
CC/35 M 83 A/A T/C G/C G/G C/C T/T G/G 
 
CC/130 M 74 A/A C/C C/C G/G C/C T/T G/G 
CC/36 M 91 A/A T/C G/C G/G C/C T/T G/G 
 
CC/131 M 98 A/A C/C C/C G/G C/C T/T G/G 
CC/37 M 92 A/A T/C G/C G/G C/C T/T G/G 
 
CC/132 M 83 A/A C/C C/C G/G C/C T/T G/G 
CC/38 M 74 A/A C/C C/C G/G C/C T/T G/G 
 
CC/133 M 85 A/A C/C C/C G/G C/C T/T G/G 
CC/39 M 78 A/A C/C C/C G/G C/T T/T G/G 
 
CC/134 M 61 A/A C/C C/C G/G C/C T/T G/G 
CC/40 M 84 A/A C/C C/C G/G C/C T/T G/G 
 
CC/135 M 73 A/A C/C C/C G/A C/C T/T G/G 
CC/41 M 84 A/A T/C G/C G/G C/C T/T G/G 
 
CC/137 M 93 A/A C/C C/C G/G C/C T/T G/G 
CC/42 M 66 A/A C/C C/C G/G C/C T/T G/G 
 
CC/138 M 84 A/A C/C C/C G/G C/C T/T G/G 
CC/43 M 80 A/A C/C C/C G/G C/C T/T G/G 
 
CC/139 M 66 A/A C/C C/C G/G C/C T/T G/G 
CC/44 M 88 A/A C/C C/C G/G C/C T/T G/G 
 
CC/140 M 89 A/A C/C C/C G/G C/C T/T G/G 
CC/45 M 82 A/T C/C C/C G/G C/C T/T G/G 
 
CC/141 M 84 A/A C/C C/C G/G C/C T/T G/G 
CC/46 M 68 A/A C/C C/C G/G C/C T/T G/G 
 
CC/142 M 75 A/A T/C G/C G/G C/C T/T G/G 
CC/50 M 66 A/A C/C C/C G/G C/C T/T G/G 
 
CC/144 M 81 A/A C/C C/C G/G C/C T/T G/G 
CC/51 M 61 A/A C/C C/C G/G C/C T/T G/G 
 
CC/145 M 91 A/A T/C G/C G/G C/C T/T G/A 
CC/52 M 74 A/A C/C C/C G/G C/C T/T G/G 
 
CC/146 M 68 A/A C/C C/C G/G C/C T/T G/G 
CC/53 M 87 A/A C/C C/C G/G C/C T/T G/G 
 
CC/147 M 55 A/A C/C C/C G/G C/C T/T G/G 
CC/54 M 80 A/A C/C C/C G/G C/C T/T G/G 
 
CC/148 M 74 A/A C/C C/C G/G C/C T/T G/G 
CC/55 M 88 A/A C/C C/C G/G C/C T/T G/G 
 
CC/149 M 96 A/A C/C C/C G/G C/C T/T G/G 
CC/56 M 74 A/A T/C G/C G/G C/C T/T G/G 
 
CC/150 M 77 A/A T/T G/G G/G C/C T/T G/G 
CC/61 M 84 A/A C/C C/C G/G C/C T/T G/G 
 
CC/151 M 76 A/T T/C G/C G/G C/C T/T G/G 
CC/62 M 88 A/A T/C G/C G/G C/C T/T G/G 
 
CC/152 M 65 A/A C/C C/C G/G C/C T/T G/G 
CC/63 M 78 A/A C/C C/C G/G C/C T/T G/G 
 
CC/153 M 68 A/A C/C C/C G/G C/C T/T G/G 
CC/64 M 70 A/A C/C C/C G/G C/C T/T G/G 
 
CC/154 M 36 A/A C/C C/C G/G C/C T/T G/G 
CC/65 M 46 A/A C/C C/C G/G C/C T/T G/G 
 
CC/155 M 86 A/A C/C C/C G/G C/C T/T G/G 
CC/66 M 87 A/A C/C C/C G/G C/C T/T G/G 
 
CC/156 M 91 A/A C/C C/C G/G C/C T/T G/G 
CC/67 M 92 A/A T/C G/C G/G C/C T/T G/G 
 
CC/157 M 96 A/A C/C C/C G/G C/C T/T G/G 
CC/76 M - A/A C/C C/C G/G C/C T/T G/G 
 
CC/158 M 63 A/A C/C C/C G/G C/C T/T G/G 
CC/77 M 68 A/A C/C C/C G/G C/C T/T G/G 
 
CC/159 M 68 A/A C/C C/C G/G C/C T/T G/G 
CC/78 M 71 A/A C/C C/C G/G C/C T/T G/G 
 
CC/160 M 72 A/A C/C C/C G/G C/C T/T G/G 
CC/83 M 84 A/A C/C C/C G/G C/C T/T G/G 
 
CC/161 M 71 A/A C/C C/C G/G C/C T/T G/G 
CC/84 M 90 A/A C/C C/C G/G C/C T/T G/G 
 
CC/162 M 37 A/A C/C C/C G/G C/C T/T G/G 
CC/85 M 78 A/A T/C G/C G/G C/C T/T G/G 
 
CC/163 M 95 A/A C/C C/C G/G C/C T/T G/G 
CC/87 M 82 A/A C/C C/C G/G C/C T/T G/G 
 
CC/164 M 80 A/A C/C C/C G/G C/C T/T G/G 
CC/88 M 65 A/A T/C G/C G/G C/C T/T G/G 
 
CC/165 M 85 A/A C/C C/C G/G C/C T/T G/G 
CC/89 M 88 A/A T/T G/G G/G C/C T/T G/G 
 
CC/166 M 66 A/A C/C C/C G/G C/C T/T G/G 
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CC/167 M 90 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/168 M 37 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/169 M 91 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/170 M 76 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/171 M - A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/172 M 93 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/173 M 87 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/174 M 78 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/175 M 80 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/176 M 59 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/177 M 85 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/178 M 76 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/179 M 76 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/180 M 95 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/181 M 76 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/184 M 74 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/185 M 68 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/186 M 77 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/187 M 85 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/188 M 64 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/189 M 82 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/190 M 78 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/192 M 75 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/193 M 72 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/194 M 55 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/198 M 86 A/A T/C G/C G/G C/C T/T G/G 
 
          
CC/198* M 11 A/A C/C C/C G/G C/C T/T G/G 
 
          
CC/199 M 66 A/A T/C G/C G/G C/C T/T G/G 
 
          
 
 
